Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up.

Journal of drugs in dermatology : JDD

Volumn 6, Issue 5, 2007, Pages 507-513

  Schiessl, Claudia ^a   Wolber, Carola ^a   Tauber, Martina ^a   Offner, Felix ^a   Strohal, Robert ^a  

^a Department of Dermatology   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT; IMIQUIMOD;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLASSIFICATION; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; SKIN TUMOR; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 34548787163     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)